CLINICAL_TRIALS
trial_result
· 2020-02-05
Clinical Trial Update: Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea [Phase 1, Phase 2]
Summary
Open-label study assessing secukinumab for papulopustular rosacea in Phase 1/2 completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Anne Chang | Conditions: Papulopustular Rosacea | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-02-05